Nitrosamine Impurities Testing

Product description

SGS Life Sciences has considerable expertise in the method development of nitrosamine determination in pharmaceutical products. SGS has established a specific method for NDMA which can be applied to various different matrices. Alternatively, a platform method, based on trace-level detection by LC-MSMS, is also available and provides rapid and simultaneous determination of up to ten different, targeted nitrosamines. Although with more limited application, the SGS network is also able to support specialist methodologies such as GC-MSMS. Our experience in optimizing extraction procedures allows application of these methods to drug products, API’s, and raw materials. 
Read more

Specifications

Categories BiopharmaceuticalsAnalytical Chemistry; APIs; Biopharmaceuticals
Sales markets Western Europe; Eastern Europe; North America
Supplied from Switzerland; United States

More products from SGS Group Management SA

View all our products (13)

Products from other suppliers

Nitrosamine Impurities Testing

Contact information

Address

Telephone

Website

View all contact information